Abstract
Renal 11β-hydroxysteroid dehydrogenases (11β-HSDs) are subject to modulation by various endogenous factors. 11β-HSDs convert glucocorticoids into inactive 11-ketones and thereby determine tissue levels of active glucocorticoids and thus the extent of glucocorticoid receptor (GR) and mineralocorticoid receptor (MR) activation. As such, modulation of the activity of renal 11β-HSDs may contribute to the cascade of regulatory events involved in renal electrolyte water handling. We investigated whether renal 11β-HSDs are modulated by elevated circulating angiotensin II. In rats infused for 2 wk with angiotensin II (250 ng/[kg.min] subcutaneously), plasma angiotensin II, aldosterone, and corticosterone were raised 5.1-, 10.7-, and 2.3-fold, respectively, compared with control rats. Angiotensin II infusion raised corticosterone 11β-oxidation 1.46- and 1.35-fold in renal cortical proximal and distal tubules (enriched by Percoll centrifugation), respectively, but had no effect on 11β-HSD1 and 11β-HSD2 mRNA levels (semiquantitative reverse transcriptase solymerase chain reaction), except for distal tubular 11β-HSD1 mRNA, which was decreased to 50%. In vitro treatment of freshly isolated tubules with angiotensin II for 45 min prior to assessment of 11β-HSD activity showed no direct acute effects of angiotensin II on tubular corticosterone 11β-oxidation. The enhanced renal tubular corticosterone 11β-oxidation in vivo may partly protect renal GR and MR from elevated plasma corticosterone on angiotensin II infusion.
Similar content being viewed by others
References
Morel, F. and Doucet, A. (1986). Physiol. Rev. 66, 377–468.
Náray-Fejes-Tóth, A. and Fejes-Tóth, G. (1990). Am. J. Physiol. 259, F672-F678.
Schafer, J. A. and Hawk, C. T. (1992). Kidney Int. 41, 255–268.
Baum, M., Moe, O. W., Gentry, D. L., and Halpern, R. J. (1994). Am. J. Physiol. 267, F432-F442.
Verrey, F., Beron, J., and Spindler, B. (1996). Miner. Electrol. Metab. 22, 279–292.
Velazquez, H., Bartiss, A., Bernstein, P., and Ellison, D. H. (1996). Am. J. Physiol. 270, F211-F219.
Schaefers, H. J. and Goppelt-Struebe, M. (1996). Biochem. Pharmacol. 52, 1415–1421.
Hayamizu, S., Kanda, K., Ohmori, S., Murata, Y., and Seo, H. (1994). Endocrinology 135, 2459–2464.
Edwards, C. R. W., Burt, D., McIntyre, M. A., De Kloet, E. R., Stewart, P. M., Brett, L., Sutanto, W. S., and Monder C. (1988). Lancet 11, 986–989.
Funder, J. W., Pearce, P. T., Smith, R., and Smith, A. L. (1988). Science 242, 583–585.
Seckl, J. R. (1993). Eur. J. Clin. Invest. 23, 589–601.
Arriza, J. L., Weinberger, C., Cerelli, G., Glaser, T. M., Handelin, B. L., Houseman, D. E., and Evans, R. M. (1987). Science 237, 268–275.
Funder, J. W., Pierce, P. T., Myles, K., and Roy, L. P. (1990). FASEB J. 4, 3234–3238.
Ulick, S., Levine, L. S., Guntzler, P., Zanconato, G., Ramirez, L. C., Rauth, W., Rosler, A., Bradlow, H. L., and New, M. I. (1979). J. Clin. Invest. 82, 340–349.
White, P. C., Mune, T., Robertson, F. M., Kayes, K. M., and Agarwal, A. K. (1997). Steroids 62, 83–88.
Kotelevtsev, Y., Brown, R. W., Fleming, S., Kenyon, C., Edwards, C. R. W., Seckl, J. R., and Mullins, J. J. (1999). J. Clin. Invest. 103, 683–689.
Stewart, P. M., Wallace, A. M., Valentino, R., Burt, D., Shackleton, C. H. L., and Edwards, C. R. W. (1987). Lancet 10, 821–823.
Souness, G. W., Latif, S. A., Laurenzo, J. L., and Morris, D. J. (1995). Endocrinology 136, 1809–1812.
Lovati, E., Ferrari, P., Dick, B., Jostarndt, K., Frey, B. M., Frey, F. J., Schorr, U., and Sharma, A. M. (1999). J. Clin. Endocrinol. Metab. 84, 3745–3749.
Franco-Saenz, R., Tokita, Y., Latif, S., and Morris, D. J. (1997). Am. J. Hypertens. 10, 1004–1009.
Takeda, Y., Inaba, S., Furukawa, K., and Miyamori, I. (1998). Hypertension 32, 1077–1082.
Agarwal, A. K., Monder, C., Eckstein, B., and White, P. C. (1989). J. Biol. Chem. 264, 18,939–18,943.
Tannin, G. M., Agarwal, A. K., Monder, C., New, M. I., and White, P. C. (1991). J. Biol. Chem. 266, 16,653–16,658.
Zhou, M. Y., Gomez-Sanchez, E. P., Cox, D. L., Cosby, D., and Gomez-Sanchez, C. E. (1995). Endocrinology 136, 3729–3733.
Smith, R. E., Li, K. X. Z., Andrews, R. K., and Krozowski, Z. (1997). Endocrinology 138, 540–547.
Roland, B. L., Krozowski, Z. S., and Funder, J. W. (1995). Mol. Cell. Endocrinol. 111, R1-R7.
Li, K. X., Smith, R. E., Ferrari, P., Funder, J. W., and Krozowski, Z. S. (1996). Mol. Cell. Endocrinol. 120, 67–75.
Alfaidy, N., Blot-Chabaud, M., Bonvalet, J.-P., and Farman, N. (1997). J. Clin. Invest. 100, 2437–2442.
Liu, Y.-L., Nakagawa, Y., and Ohzeki, T. (1998). Hypertension 31, 885–889.
Niepel, T., Maser, E., and Hermans, J. J. R. (1997). Pharmacol. Toxicol. 80, 127–131.
Hermans, J. J. R., Fischer, M. A. J., Schiffers, P. M., and Struijker-Boudier, H. A. J. (1999). Biochim. Biophys. Acta 1472, 537–549.
Riddle, M. C. and McDaniel, P. A. (1994). J. Clin. Endocrinol. Metab. 78, 830–834.
Mckinell, J., Roscoe, D., Holmes, M. C., Lloyd-Macgilp, S. A., and Kenyon, C. J. (2000). Endocr. Res. 26, 81–95.
Escher, G., Vogt, B., Beck, T., Guntern, D., Frey, B. M., and Frey, F. J. (1998). Endocrinology 139, 1533–1539.
Escher, G., Nawrocki, A., Staub, T., Vishwanath, B. S., Frey, B. M., Reichen, J., and Frey, F. J. (1998). Gastroenterology 114, 175–184.
Ackermann, D., Vogt, B., Escher, G., Dick, B., Reichen, J., Frey, B. M., and Frey, F. J. (1999). Hepatology 30, 623–629.
Hall, J. E., Mizelle, H. L., and Woods, L. L. (1986). J. Hypertens. 4, 387–397.
Quinn, S. J. and Williams, G. H. (1988). Annu. Rev. Physiol. 50, 409–426.
Lebrethon, M. C., Jaillard, C., Defayes, G., Begeot, M., and Saez, J. M. (1994). J. Clin. Endocrinol. Metab. 78, 1212–1219.
Sato, A., Suzuki, H., Murakami, M., Nakazato, Y., Awaita, Y., and Saruta, T. (1994). Hypertension 23, 25–30.
Brem, A. S., Bina, R. B., Fitzpatrick, C., King, T., Tang, S. S., and Ingelfinger, J. R. (1999). Proc. Soc. Exp. Biol. Med. 221, 111–117.
Stassen, F. R. M., Raat, N. J. H., Brouwers-Ceiler, D. L., Fazzi, G. E., Smits, J. F. M., and De Mey, J. G. R. (1997). J. Vasc. Res. 34, 289–297.
Griffin, S. A., Brown, W. C. B., MacPherson, F., McGrath, J. C., Wilson, V. G., Korsgaard, N., Mulvany, M. J., and Lever, A. F. (1991). Hypertension 17, 626–635.
Kenouch, S., Alfaidy, N., Bonvalet, J.-P., and Farman, N. (1994). Steroids 59, 100–104.
Alfaidy, N., Blot-Chabaud, M., Robic, S., Kenouch, S., Bourbouze, R., Bonvalet, J.-P., and Farman, N (1995). Biochim. Biophys. Acta 1243, 461–468.
Low, S. C., Chapman, K. E., Edwards, C. R. W., Well, T., Robinson, C. A. F., and Seckl, J. R. (1994). J. Endocrinol. 143, 541–548.
Ricketts, M. L. and Stewart, P. M. (1999). Clin. Sci. 96, 669–675.
Lombes, M., Kenouch, S., Souque, A., Farman, N., and Rafestin-Oblin, M. E. (1994). Endocrinology 135, 834–840.
Leckie, C., Chapman, K. E., Edwards, C. R. W., and Seckl, J. R. (1995). Endocrinology 136, 5561–5569.
Demers, L. M., Sampson, E., and Hayes, A. H. (1976). Clin. Biochem. 9, 243–246.
Nussberger, J., Waeber, G., Waeber, B., Bidiville, J., and Brunner, H. R. (1988). J. Cardiovasc. Pharmacol. 77, 716–721.
Mason, S. R., Ward, L. C., and Reilly, P. E. (1992). J. Chromatogr. 581, 267–271.
Smith, P. K., Krohn, R. I., Hermanson, G. T., Mallia, A. K., Gartner, F. H., Provenzano, M. D., Fujimoto, E. K., Goeke, N. M., Olson, B. J., and Klenk, D. C. (1985). Anal. Biochem. 150, 76–85.
Meaney, M. J., Aitken, D. H., Sharma, A., and Viau, V. (1992). Neuroendocrinology 55, 204–213.
Shan, L. X., Hardy, D. O., Catterall, J. F., and Hardy, M. P. (1993). Endocrinology 136, 1686–1693.
Sachs, L. (1983) Angewandte Statistik. Springer: Berlin.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hermans, J.J.R., Fischer, M.A.J., Schiffers, P.M. et al. Effect of angiotensin II on rat renal cortical 11β-hydroxysteroid dehydrogenase. Endocr 13, 393–399 (2000). https://doi.org/10.1385/ENDO:13:3:393
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/ENDO:13:3:393